BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25853237)

  • 1. Low-Molecular-Weight Heparins as Immunomodulators in Dermatology Practice.
    Solak B
    Am J Ther; 2016; 23(6):e1911-e1917. PubMed ID: 25853237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Synacthen-depot in dermatology (author's transl)].
    Dubois-Ferrière G; Hunziker N; Orusco M
    Dermatologica; 1974; 148(2):65-71. PubMed ID: 4366321
    [No Abstract]   [Full Text] [Related]  

  • 3. Adverse skin reactions to low molecular weight heparins: frequency, management and prevention.
    Wütschert R; Piletta P; Bounameaux H
    Drug Saf; 1999 Jun; 20(6):515-25. PubMed ID: 10392668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulants in dermatology.
    Adya KA; Inamadar AC; Palit A
    Indian J Dermatol Venereol Leprol; 2016; 82(6):626-640. PubMed ID: 27320765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed-type hypersensitivity and cross-reactivity to heparins and danaparoid: a prospective study.
    Grassegger A; Fritsch P; Reider N
    Dermatol Surg; 2001 Jan; 27(1):47-52. PubMed ID: 11231243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of severe cutaneous ulcerative lichen planus with low molecular weight heparin in a patient with hepatitis C.
    Neville JA; Hancox JG; Williford PM; Yosipovitch G
    Cutis; 2007 Jan; 79(1):37-40. PubMed ID: 17330620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A world of low molecular weight heparins (LMWHs) enoxaparin as a promising moiety--a review.
    Ingle RG; Agarwal AS
    Carbohydr Polym; 2014 Jun; 106():148-53. PubMed ID: 24721062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-induced skin necrosis and low molecular weight heparins.
    Drew PJ; Smith MJ; Milling MA
    Ann R Coll Surg Engl; 1999 Jul; 81(4):266-9. PubMed ID: 10615196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed-type hypersensitivity to low molecular weight heparins and heparinoids: cross-reactivity does not depend on molecular weight.
    Grims RH; Weger W; Reiter H; Arbab E; Kränke B; Aberer W
    Br J Dermatol; 2007 Sep; 157(3):514-7. PubMed ID: 17573880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of low molecular weight heparin in the treatment of cutaneous lichen planus.
    Khan SI; Khondker L
    Mymensingh Med J; 2012 Oct; 21(4):668-73. PubMed ID: 23134915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of skin- and venereal diseases. Review of the literature 1969].
    Walther H
    Dtsch Med J; 1970 Jun; 21(12):870-6 passim. PubMed ID: 4259633
    [No Abstract]   [Full Text] [Related]  

  • 12. [Possibilities and limitations of the use of Synacthen Depot Ciba in dermatology].
    Ormea F; Muscardin L; Rusciani L; Garcovich A
    Minerva Med; 1970 Sep; 61(78):4261-7. PubMed ID: 4325284
    [No Abstract]   [Full Text] [Related]  

  • 13. Low molecular weight heparins in the long-term treatment of venous thromboembolism.
    Liapis CD; Daskalopoulos ME; Daskalopoulou SE
    J Cardiovasc Surg (Torino); 2002 Aug; 43(4):495-500. PubMed ID: 12124561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ulcerative lichen planus of the sole: excellent response to topical tacrolimus.
    Al-Khenaizan S; Al Mubarak L
    Int J Dermatol; 2008 Jun; 47(6):626-8. PubMed ID: 18477162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generic low-molecular-weight heparins: some practical considerations.
    Fareed J; Leong WL; Hoppensteadt DA; Jeske WP; Walenga J; Wahi R; Bick RL
    Semin Thromb Hemost; 2004 Dec; 30(6):703-13. PubMed ID: 15630677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Warfarin necrosis.
    Balotti RF; Malone RJ; Schanzer RJ
    Am J Phys Med Rehabil; 2009 Apr; 88(4):263. PubMed ID: 19300035
    [No Abstract]   [Full Text] [Related]  

  • 17. Skin reactions due to low molecular weight heparin in pregnancy: a strategic dilemma.
    Verdonkschot AE; Vasmel WL; Middeldorp S; van der Schoot JT
    Arch Gynecol Obstet; 2005 Feb; 271(2):163-5. PubMed ID: 15112083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Low molecular weight heparins and their non-antithrombotic effects on wound healing].
    Toporcer T; Lakyová L; Radonak J
    Cas Lek Cesk; 2009; 148(10):481-8. PubMed ID: 20662410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dermatology and the effects of medication on the skin].
    Sassolas B; Duong TA
    Soins; 2010 Sep; (748):42-4. PubMed ID: 20963979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is low-molecular-weight heparin beneficial to chronic ulcers? A meta-analysis of randomised control trials.
    Huang CY; Choong MY
    Int Wound J; 2017 Jun; 14(3):589-590. PubMed ID: 28194882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.